Bluebook
Diagnostics & Tools January 2020
2020 - January: Report on M&A and financing activity in the diagnostics and tools industry for CEOs and private equity professionals
Crosstree BlueBooks provide an executive review of key health sciences transactions, financial movements, and public market activity. BlueBooks also offer a glimpse of how valuations are changing and how recent trends may affect future transactions.
- Blueprint Genetics acquired by Quest Diagnostics
- Andrew Alliance to be acquired by Waters Corporation
- Insight Genetics to be acquired by OncoCyte
- NeXtal Biotechnologies acquired by CalibreScientific